Big Pharma company orders third HoloMonitor

A current pharma customer recently ordered its third Holo­Monitor® unit. The ordered configuration is the automated stage version of the Holo­Monitor platform. The total retail price of the ordered units amounts to €90 000.

“The follow-up order from a world leading Swiss pharma company confirms the market potential within Big Pharma and the pharmaceutical industry in general. Big Pharma’s interest shows that our Holo­Monitor technology is rapidly becoming established and highlight the importance of our goal to create a Center of Excellence in the Basel area”, said CEO Peter Egelberg.

The pharmaceutical industry in Switzerland directly and indirectly employs close to 170 000 people and approximately contributes with 30% of the country’s exports. Basel is the home of two largest Big Pharma companies in the world, Novartis and Roche.